Latest filing published 15 Sept 2018 for RISE Life Science Corp..
No signal scores available.
All filings by Christopher Hugh Dollard on record concern RISE Life Science Corp. Over a trading history stretching from 14 March 2018 to 12 September 2018, the count stands at 5 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 15 September 2018: a transaction, in RISE Life Science Corp. Typically, a trade is published a median of 3 days after it takes place. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations